United States · FDA National Drug Code directory
Lidocaine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-116_4f57a343-a57e-f9bf-e063-6394a90a3eb2
- Product NDC
- 31722-116
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Lidocaine hydrochloride
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211108
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE ANHYDROUS — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, MULTI-DOSE in 1 CARTON (31722-116-31) / 20 mL in 1 VIAL, MULTI-DOSE (31722-116-20) · 31722-116-31
- 10 VIAL, MULTI-DOSE in 1 CARTON (31722-116-32) / 20 mL in 1 VIAL, MULTI-DOSE (31722-116-20) · 31722-116-32
- 25 VIAL, MULTI-DOSE in 1 CARTON (31722-116-33) / 50 mL in 1 VIAL, MULTI-DOSE (31722-116-50) · 31722-116-33
- 10 VIAL, MULTI-DOSE in 1 CARTON (31722-116-34) / 50 mL in 1 VIAL, MULTI-DOSE (31722-116-50) · 31722-116-34
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →